Fast Track Designation (FTD) granted for the treatment of patients with metastatic PDAC with high IL1RAP expression levels.Reflects high unmet medical need in metastatic PDAC.Facilitates further ...

GOTHENBURG, SWEDEN / ACCESS Newswire / June 11, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Today, on Wednesday June 11, 2025, IRLAB Therapeutics AB held its Annual General Meeting.The ...

KITCHENER, ON / ACCESS Newswire / June 11, 2025 / Cloud DX Inc. ("Cloud DX") (TSXV:CDX)(OTCQB:CDXFF) reports that it has received a Cease Trade Order from the Ontario Securities Commission (OSC) on ...

Key Takeaways from NEXT Pharma 2025At NEXT Pharma 2025, one message resonated across every panel, and breakout session: AI is ...

The landscape of clinical trials is rapidly transforming. As we move through 2025, smarter technologies and patient-centric ...

Notable Systems continues to expand its executive team with two key appointments: Brian Nannie, former Chief Data Officer at Lincare, joins as Senior Vice President of Client Strategy & Innovation, ...

Thrive Medical Billing, a premier medical billing and coding company, is setting new standards in the healthcare industry by ...

To obtain full approval of the drug for treatment of chemotherapy-induced diarrhea (CID) and to expand the indication of crofelemer from CID to treatment of general, non-infectious diarrhea in ...

MISSOULA, MONTANA / ACCESS Newswire / June 11, 2025 / Venture Medical, LLC, a leader in wound care solutions, today announced its acquisition of certain assets of ProgenaCare Global, LLC, a ...

FRANKLIN, NJ / ACCESS Newswire / June 11, 2025 / Silver Scott Health, Inc., a division of Silver Scott Mines, Inc. (OTC Pink:SILS), today announced the upcoming launch of its "Talk to a Nurse" feature ...

OKYO Pharma to Present at the Bio International ConventionLONDON and NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company ...

Iterum Therapeutics Announces Partnership for Commercialization Services U.S. Commercial Launch of ORLYNVAHTM by Q4 2025; First Oral Penem Available in the U.S. Management to host a conference call at ...